ai

XIAO-I

AIXI
NASDAQ
$2.02

Quelle est l'efficacité de la stratégie d'allocation de capital de XIAO-I ?

Capital allocation has centered on survival financing rather than shareholder value creation.

The company executed reverse ADS ratio changes in August 2024 (1‑for‑9), May 2026 (1‑for‑20) and announced another effective around September 8, 2026 (1‑for‑7), while entering multiple convertible notes with variable conversion prices and original‑issue discounts.

Shares outstanding rose from 31.95M to 55.24M in 2025 through conversions and issuances, and further dilution is embedded in 2026 financing. These actions kept the listing alive temporarily but transferred value to lenders and created persistent overhang.